ReviewCancers2022

Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain.

Bich Phuong Bui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.